0001123292-25-000190.txt : 20250505 0001123292-25-000190.hdr.sgml : 20250505 20250505160627 ACCESSION NUMBER: 0001123292-25-000190 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 EFFECTIVENESS DATE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-545248 FILM NUMBER: 25912929 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: SUITE 8500 CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: 212-220-6633 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: SUITE 8500 CITY: NEW YORK STATE: NY ZIP: 10007 D 1 primary_doc.xml X0708 D LIVE 0001813814 Mind Medicine (MindMed) Inc. One World Trade Center Suite 8500 New York NY NEW YORK 10007 212-220-6633 BRITISH COLUMBIA, CANADA None None Corporation true Robert Barrow One World Trade Center Suite 8500 New York NY NEW YORK 10007 Director Executive Officer Matt Wiley One World Trade Center Suite 8500 New York NY NEW YORK 10007 Executive Officer Daniel Karlin One World Trade Center Suite 8500 New York NY NEW YORK 10007 Executive Officer Carrie Liao One World Trade Center Suite 8500 New York NY NEW YORK 10007 Executive Officer Mark R. Sullivan One World Trade Center Suite 8500 New York NY NEW YORK 10007 Executive Officer Suzanne Bruhn One World Trade Center Suite 8500 New York NY NEW YORK 10007 Director Roger Crystal One World Trade Center Suite 8500 New York NY NEW YORK 10007 Director Andreas Krebs One World Trade Center Suite 8500 New York NY NEW YORK 10007 Director Carol A. Vallone One World Trade Center Suite 8500 New York NY NEW YORK 10007 Director David Gryska One World Trade Center Suite 8500 New York NY NEW YORK 10007 Director Pharmaceuticals Decline to Disclose 06b false 2023-08-11 false true true Term loan, $7,000,000 of which is convertible into common shares. false 0 7000000 7000000 0 Term loan, $7,000,000 of which is convertible into common shares. false 1 0 0 0 false Mind Medicine (MindMed) Inc. /s/ Mark R. Sullivan Mark R. Sullivan Chief Legal Officer 2025-05-05